Table 1.
General characteristics of the participants in the study and gender distribution.
| Variable | All | Males | Females | ||||||
|---|---|---|---|---|---|---|---|---|---|
| T1DM (n = 118) | CG (n = 94) | p | T1DM (n = 53) | CG (n = 42) | p | T1DM (n = 65) | CG (n = 52) | p | |
| Age (years) | 30.12 ± 8.78 | 29.81 ± 7.60 | 0.311 | 29.19 ± 7.74 | 28.73 ± 6.61 | 0.867 | 31.05 ± 8.19 | 30.89 ± 7.88 | 0.101 |
| Height (cm) | 170 ± 10 | 171 ± 9 | 0.428 | 178 ± 7 | 180 ± 6 | 0.357 | 163 ± 6 | 164 ± 5 | 0.413 |
| Weight (kg) | 74.65 ± 15.29 | 78.67 ± 16.08 | 0.070 | 82.16 ± 13.48 | 87.82 ± 14.23 | 0.054 | 68.52 ± 13.96 | 71.21 ± 13.52 | 0.304 |
| BMI (kg/m2) | 25.74 ± 4.78 | 26.59 ± 4.73 | 0.164 | 25.64 ± 3.87 | 27.00 ± 4.05 | 0.102 | 25.39 ± 4.24 | 26.26 ± 5.22 | 0.650 |
| Age of diagnosis (years) | 19.17 ± 9.80 | — | — | 19.62 ± 10.45 | — | — | 18.80 ± 9.30 | — | — |
| Disease duration (years) | 16.16 ± 9.56 | — | — | 15.72 ± 9.40 | — | — | 16.52 ± 9.76 | — | — |
| HbA1c (%) | 7.85 ± 1.43 | 5.12 ± 0.26 | ≤0.001 | 7.80 ± 1.25 | 5.13 ± 0.27 | ≤0.001 | 7.88 ± 1.56 | 5.11 ± 0.26 | ≤0.001 |
| β-Crosslaps (pg/ml) | 329.16 ± 199.87 | 442.81 ± 220.66 | 0.001 | 302.79 ± 130.46 | 481.55 ± 119.45 | 0.028 | 262.94 ± 139.89 | 368.81 ± 133.35 | 0.005 |
| TP1NP (pg/ml) | 51.98 ± 33.25 | 53.12 ± 24.43 | 0.178 | 62.01 ± 39.89 | 66.30 ± 34.72 | 0.589 | 43.07 ± 22.96 | 46.53 ± 13.73 | 0.392 |
Data are expressed as mean ± SD. n: number of patients; BMI: body mass index.